# Plain Language Summary: Securing America From Epidemics Act

This bill authorizes the United States to officially join and participate in an international organization called the Coalition for Epidemic Preparedness Innovations (CEPI). Think of CEPI as a global team of countries and private organizations working together to develop vaccines for diseases that could become epidemics before they actually spread widely. The organization was created in 2017 specifically to fill a gap: when a new disease emerges, there's often no financial incentive for drug companies to develop vaccines quickly because there's no established market yet. CEPI steps in to fund and coordinate vaccine development in these urgent situations, getting promising vaccine candidates through early testing phases and preparing them for rapid deployment if needed.

The bill essentially gives the U.S. government the green light to contribute money to CEPI and have a seat at the table in how the organization operates. The President would designate a U.S. representative with expertise in public health or medicine to participate in CEPI's decision-making bodies. The bill points out that CEPI already helped fund development of the Moderna COVID-19 vaccine and coordinated work on multiple COVID vaccines through an initiative called COVAX, which aimed to distribute vaccines fairly across countries. By joining officially, the U.S. would be pooling resources with other nations rather than going it alone, which the bill argues makes sense for American health security and national interests.

Within six months of the bill passing, the President would need to report to Congress about how much money the U.S. plans to contribute, how it will participate in CEPI's governance, and how this participation fits into broader U.S. health security and biodefense strategies. The funding would come from existing foreign aid budget categories, so no new money would necessarily be required—it would be redirected from existing international health programs. For ordinary Americans, this means the government is investing in a system designed to catch and contain emerging disease threats before they become pandemics, potentially preventing future health crises and their economic damage.

Securing America From Epidemics Act

Securing America From Epidemics Act This bill authorizes the United States to participate in the Coalition for Epidemic Preparedness Innovations, an alliance of countries and private partners whose mission is to finance and coordinate the development of vaccines for high-priority, epidemic-potential threats. The President must report on certain matters concerning U.S. participation in coalition activities, including how this participation supports health security and biodefense priorities.